Salma Abbas

Virginia Commonwealth University

Papers

1

Total Citations

58

H-Index

1

About

Dr. Salma Abbas is a leading voice in healthcare epidemiology and infection prevention, whose work has reshaped hospital infection control practices. Her research focuses on the practical, evidence-based management of multidrug-resistant organisms, particularly methicillin-resistant *Staphylococcus aureus* (MRSA) and vancomycin-resistant *Enterococcus* (VRE). Dr. Abbas’s most impactful contribution is her landmark 2018 study, which rigorously challenged the long-held dogma of routine contact precautions for these pathogens. In a single-center, quasi-experimental analysis cited 58 times, she demonstrated that discontinuing contact precautions did not lead to an increase in healthcare-associated infections. This pivotal finding provided crucial evidence for a paradigm shift, allowing hospitals to reduce patient isolation burdens, conserve resources, and improve patient flow without compromising safety. By questioning established protocols, Dr. Abbas has directly influenced national guidelines and empowered institutions to adopt more patient-centered, efficient infection control strategies, marking her as a key figure in the movement toward evidence-based de-escalation of isolation practices.

Research Focus

Key Achievements

1
H-Index
1
Papers
58
Total Citations
58
Avg Citations/Paper
🏆 Most Cited Paper
Impact of Discontinuing Contact Precautions for Methicillin-Resistant <i>Staphylococcus aureus</i> and Vancomycin-Resistant <i>Enterococcus</i> : An Interrupted Time Series Analysis
58 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Virginia Commonwealth University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago